Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37°C and high humidity

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 33-36

  García Lerma, J Gerardo ^a   McNulty, Amanda ^a   Jennings, Cheryl ^b   Huang, Diana ^b   Heneine, Walid ^a   Bremer, James W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

903 filter paper; DBS storage; Drug resistance surveillance; RNA stability

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 POLYMERASE; RNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; DRIED BLOOD SPOT; DRIED PLASMA SPOT; GENOTYPE; HIGH TEMPERATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMIDITY; IMMUNOASSAY; NUCLEIC ACID AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA EXTRACTION; RNA SEQUENCE; STORAGE TEMPERATURE;

BLOOD; DESICCATION; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV-1; HUMANS; HUMIDITY; PLASMA; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPECIMEN HANDLING; TEMPERATURE;

EID: 67249150479     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp150     Document Type: Article

References (13)

1. UNAIDS. 2007 AIDS Epidemic Update. http://www.unaids.org/en/ KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp (10 March 2009, date last accessed).
2. Akilerswaran C, Lurie MN, Flanigan TP et al. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis 2005; 41: 376-85.
3. Nkengasong JN, Adje-Toure C, Weidle PJ. HIV antiretroviral drug resistance in Africa. AIDS Rev 2004; 6: 4-12.
4. Spacek LA, Shihab HM, Kamya MR et al. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis 2006; 42: 252-9.
5. Bennett DE, Bertagnolio S, Sutherland D et al. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008; 13 Suppl 2: 1-13.
6. Buckton AJ. New methods for the surveillance of HIV drug resistance in the resource poor world. Curr Opin Infect Dis 2008; 21: 653-8.
7. Masciotra S, Garrido C, Youngpairoj AS et al. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 2007; 21: 2503-11.
8. Youngpairoj AS, Masciotra S, Garrido C et al. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C. J Antimicrob Chemother 2008; 61: 1217-20.
9. McNulty A, Jennings C, Bennett D et al. Evaluation of dried blood spots for HIV-1 drug resistance testing. J Clin Microbiol 2007; 45: 517-21.
10. Garrido C, Zahonero N, Fernándes D et al. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J Antimicrob Chemother 2008; 61: 694-8.
11. Bertagnolio S, Soto-Ramirez L, Pilon R et al. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir Ther 2007; 12: 107-13.
12. Bertagnolio S, Derdelinckx I, Parker M et al. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther 2008; 13 Suppl 2: 49-57.
13. Buckton AJ, Bissett SL, Myers RE et al. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J Antimicrob Chemother 2008; 62: 1191-8.